Uranium Conversion Facility
Sector: Warehouse • Location: United States
Source: AD HOC NEWS
A proposed uranium conversion plant designed to process mined uranium into a form suitable for enrichment, addressing a key bottleneck in the domestic nuclear industry. Engineering firm Fluor is providing technical support, and potential sites within the United States are being evaluated for construction.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | planned |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | A proposed uranium conversion plant designed to process mined uranium into a form suitable for enrichment, addressing a key bottleneck in the domestic nuclear industry. Engineering firm Fluor is providing technical support, and potential sites within the United States are being evaluated for construction. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
More Warehouse projects in United States
- Morphotek’s New Biologics Production Facility
- Bristol-Myers Squibb Manufacturing Plant, Devens, Massachusetts
- Cambridge Major Laboratories Active Pharmaceutical
- CoreRx’s New Product Development Centre, Florida
- Eli Lilly’s Parenteral Product and Device Manufacturing Facility, Concord, North Carolina
- Roche Diagnostics PCR Diagnostic Kits
- Vetter Small-Scale Fill-Finish Facility, Chicago
- Novartis Vaccine Manufacturing Facility, North Carolina
